BioHealth Innovation
If you are having trouble viewing this email, please click here

February 26, 2019


2/28 SBIR & Non-Dilutive Funding Workshop

University of Maryland Institute for Bioscience & Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD 20850

Register NOW:

  • 8:00 a.m. – Networking and Registration
  • 8:30 a.m. – Welcome
  • 8:35 a.m. – SBIR Funding Opportunities at the National Institutes of Health
    • National Heart, Lung, and Blood Institute
    • National Institute on Aging
    • National Institute on Drug Abuse
    • National Cancer Institute  
  • 9:45 a.m. – Partnership Opportunities with NCI Frederick National Lab  
  • 10:00 a.m. – BREAK
  • 10:20 a.m. – SBIR Funding Opportunities with the National Science Foundation    
  • 11:00 a.m. – BREAK  
  • 11:15 a.m. – SBIR Funding Opportunities with USAMRC    
  • 11:45 a.m. –  Lunch  
  • 12:45 p.m. – (1:1 Room Set)  
  • 1:00 p.m. – Writing Your Specific Aims Page OR 1:1 Meetings* (available simultaneously)  
  • 1:30 p.m. – Writing Your Phase II Commercialization Plan OR 1:1 Meetings* (available simultaneously)  
  • 2:00 p.m. – Writing Your Specific Aims Page OR 1:1 Meetings* (available simultaneously)  
  • 2:30 p.m. –  Writing Your Phase II Commercialization Plan  OR 1:1 Meetings* (available simultaneously))  
  • 3:00 p.m. –  1:1 Meetings* (NIH only)  
  • 4:00 p.m. – Adjourn

Pre-Registration REQUIRED: RSVP by noon, February 26 at charge for entrepreneurs to attend • NOTE: Most 1:1 meeting(s) timeslots now are booked but when you list your agency interests in the RSVP we will be certain to let them know to follow up with you with more information.

Read More




Submit your application for a chance to be named the Startup with the Most Commercial Potential at the BioHealth Capital Region Forum, win $10,000 and more!






Finalists will have a chance to win the grand prize by presenting in front of a panel of prominent industry funding experts and executives.

Distinguished Judges:

Moderator - Rich Bendis, President and CEO, BioHealth Innovation

2019 Judges


  • John Rubin, Executive Director, JP Morgan Private Bank
  • Charles J. Andres, Intellectual Property Associate, Wilson Sonsini Goodrich & Rosati (WSGR)
  • Raghav Bhargava, Associate, New Enterprise Associates (NEA)
  • Ethel Rubin, NIH Entrepreneur in Residence
  • Shaun Grady, Vice-President Business Development Operations, AstraZeneca



Grand Prize provided by WSGR $10,000

Visibility in front of hundreds of attendees and prominent industry and venture capital judges


Product, Technical Feasibility, Marketing/Strategy, Leadership Team, Financial/Projection

Read More

SAVE THE DATE - 2019 BioHealth Capital Region Forum

April 8 + 9, 2019

One MedImmune Way, Gaithersburg, MD 20878

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Maryland Tech Council, University System of Maryland, Children’s National Health Network, HemoShear, GSK, BeneVir, Quality Biological, Johns Hopkins University and AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

Register at

For more information about our speakers and event schedule, please visit

Read More

Danaher acquires GE Biopharma for $21.4B - Washington Business Journal

The deal is expected to close in the fourth quarter of this year.

Read More

BioHealth Innovation Entrepreneur-in-Residence Feedback - Feb. 27th

Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan?  Sign up by noon 3/26 to schedule your feedback session with BHI Entrepreneurs-in-Residence, who have industry experience in therapeutics, Dx, medtech and more, next Wednesday, February 27th.  (Future sessions scheduled for 3/20 and 5/22.)  Pre-registration is required; sign up here ("EIR resource" at BHI).  For questions/more information, contact BHI.

Read More

EXCLUSIVE: Amazon Real Estate Head Holly Sullivan Has No Regrets About The HQ2 Search

Amazon changed the rules of economic development when it announced a 50,000-job HQ2 sweepstakes in 2017. While most searches for large facilities happen behind closed doors, the Seattle tech giant kicked off an unprecedented, high-stakes, public battle for its next corporate home.

Read More

Maryland still outpacing California among best science, tech environments - Baltimore Business Journal

Maryland has the most computer and data scientists in the U.S., and the second-highest concentrations of engineers and life scientists.

Read More

RoosterBio Announces Plans to Expand Facility in Frederick, MD

RoosterBio, Inc, a privately held regenerative medicine manufacturing platform technology company announced plans today to expand the company’s footprint in Frederick, MD after a year of rapid growth.

Read More

Qiagen Gets Access to the Largest Genetic Database on Antibiotic Resistance

Under a new licensing deal, Qiagen will gain access to a big genetics database from Vienna-based Ares Genetics, which could help tackle the global health crisis of antibiotic resistance.

Read More

Microsoft, global health organizations launch 3 tech programs to catch rare diseases in children

Microsoft outlined how emerging technologies can support diagnosis of rare diseases among children in a report released Feb. 20.

Rare diseases affect almost 350 million people globally, and they can take an average of five years to diagnose, according to the report.

Read More

Antidote Therapeutics teams up with National Cancer Institute, seeks funding for nicotine-blocking drug candidate - Washington Business Journal

Matt Kalnik wants to make smoking less addictive.

His clinical-stage company, Gaithersburg-based Antidote Therapeutics Inc., is developing a drug that would diminish the effects of nicotine in the body — to both treat diseases worsened by nicotine and help smokers quit. The businesses is looking to raise between $5 million and $10 million to run over the next two years and get its lead candidate to clinical trials.

Read More

Maryland Momentum Fund accepting applications | Office of Technology Commercialization

The Maryland Momentum Fund is a newly-created mechanism for investing in promising early stage companies associated with the University System of Maryland (USM). Maryland-based companies that are seeking equity financing or debt financing that is convertible into equity may apply. The funding provided by the Fund will normally be in the range of $150K-$250K, with a ceiling of $500K. Recipients of this funding must obtain a matching investment (1:1) within six months, in either direction, from the date of commitment by the Fund.

Read More

TEDCO Creates Task Force to Support Women Entrepreneurs in Maryland

The Maryland Technology Development Corporation (TEDCO) announced today the formation of the Task Force for Women Entrepreneurs. The task force will be dedicated to the recruitment, funding, and operational support of women-owned and-led startups in Maryland.

Read More

University of Maryland Greenebaum Comprehensive Cancer Center Now Among Select Institutions Certified to Administer CAR T-cell Therapy for Lymphoma | UM Greenebaum Comprehensive Cancer Center

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is now certified to offer a groundbreaking treatment for non-Hodgkin lymphoma, in which a patient’s own immune cells are genetically engineered to recognize and attack the cancer.

Read More

Top 10 Immuno-Oncology Startups - GEN - Genetic Engineering and Biotechnology News

GlaxoSmithKline (GSK)’s recently announced $4.2 billion partnership to co-develop and co-commercialize Merck KGaA, Darmstadt’s cancer immunotherapy candidate M7824 was a reminder of just how much biopharma giants are willing to invest in a therapeutic area that has generated sometimes-dazzling results.

Read More

Kauffman Indicators of Entrepreneurship

The Kauffman Indicators of Entrepreneurship offers in-depth measures, reports, and accompanying interactive data visualizations that present entrepreneurial trends in the United States.

Read More

Like the rest of biopharma investors, corporate VCs love oncology | Evaluate

Novartis scatters its VC seeds widely by leading rounds across a variety of therapy areas, although oncology still represents a big share of its funding activity.

Read More

If We Don't Develop Best Practices Ourselves, the Government Will

To spare you all a power point presentation, I thought I’d share some thoughts today about how and why our tech transfer system was created and the importance of practitioners continually developing best practices to maintain it.

Woody Allen said that half of life is showing up. Perhaps the other half is working with people who give you the opportunity to show what you can do.

Read More

MPM Capital raises $400M in seventh venture fund - MedCity News

A life sciences-focused venture capital firm based near Boston has raised more than one-third of a billion dollars to invest in early-stage companies.

Read More

Why Food Could Be the Best Medicine of All - Time

When Tom Shicowich’s toe started feeling numb in 2010, he brushed it off as a temporary ache. At the time, he didn’t have health insurance, so he put off going to the doctor. The toe became infected, and he got so sick that he stayed in bed for two days with what he assumed was the flu. When he finally saw a doctor, the physician immediately sent Shicowich to the emergency room. Several days later, surgeons amputated his toe, and he ended up spending a month in the hospital to recover.

Read More

Home | About BHI | BHI News | Programs | Partners | Contact

Copyright © BioHealth Innovation 2017
All Rights Reserved.